Cerenome (CNSY) Cash & Current Investments (2010 - 2026)
Powered by 
Analysis
Cerenome (CNSY) Cash & Current Investments (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 7.99 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 5.18 Bn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 5.14 Bn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 5.10 Bn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 3.31 Bn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 836.99 Mn |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 1.16 Bn |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | 8.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.59 Mn |
| Mar 31, 2026 | 15.11 Mn |
| Dec 31, 2025 | 8.86 Mn |
| Sep 30, 2025 | 16.60 Mn |
| Jun 30, 2025 | 6.88 Mn |
| Mar 31, 2025 | 9.87 Mn |
| Dec 31, 2024 | 3.61 Mn |
| Sep 30, 2024 | 4.79 Mn |
| Jun 30, 2024 | 8.44 Mn |
| Mar 31, 2024 | 3.60 Mn |
| Dec 31, 2023 | 8.55 Mn |
| Sep 30, 2023 | 11.01 Mn |
| Jun 30, 2023 | 10.90 Mn |
| Mar 31, 2023 | 12.72 Mn |
| Dec 31, 2022 | 18.12 Mn |
| Sep 30, 2022 | 20.27 Mn |
| Jun 30, 2022 | 18.09 Mn |
| Mar 31, 2022 | 21.24 Mn |
| Dec 31, 2021 | 18.40 Mn |
| Sep 30, 2021 | 21.28 Mn |